GYRE
Gyre Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.86
+6.52%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 3.80x
- P/S forward
- 12.56x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.58x
- Price / sales
- 6.09x
- Price / cash flow
- -50.18x
Enterprise value
- Enterprise value
- $713.0M
- EV / sales
- 5.97x
- EV / EBITDA
- -50.83x
- EV / EBIT
- -42.76x
- Market cap
- $727.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026